Immune Pharmaceuticals, Inc. Message Board

  • kristerlag kristerlag Dec 6, 2010 5:09 PM Flag

    EpiCept Announces Ceplene® Poster Presentation

    Posted : Mon, 06 Dec 2010 02:32:41 GMT
    Author : EpiCept Corporation: 777 Old Saw Mill River Road Tarrytown, NY 10591 Robert W. Cook (914) 606-3500 rcook@epicept.com Investors: Lippert/Heilshorn & Associates Kim Sutton Golodetz (212) 838-3777 kgolodetz@lhai.com or Bruce Voss (310)
    Category : Press Release
    News Alerts by Email ( click here )
    Press Release News | Home

    TARRYTOWN, N.Y. - (Business Wire) EpiCept Corporation (Nasdaq and Nasdaq OMX Stockholm Exchange: EPCT) announced today that an abstract for Ceplene® was presented at the 52nd Annual Meeting and Exposition of the American Society of Hematology (ASH), taking place December 4-7, 2010, in Orlando, Florida. The Abstract, Number 2182 (Poster Board II-62) was presented today between 6:00 PM-8:00 PM in Hall A3/A4. The Abstract is entitled “Incremental Benefit of Histamine Dihydrochloride When Added to Interleukin-2 for Remission Maintenance in Acute Myeloid Leukemia: A Bayesian Meta-analysis” and was authored by Scott M. Berry, PhD and Kristine R. Broglio, MS, Berry Consultants, LLC, College Station, TX; Donald A. Berry, PhD, Berry Consultants, LLC and Division of Quantitative Sciences, The University of Texas M.D. Anderson Cancer Center, Houston, TX.


    http://www.earthtimes.org/articles/press/meeting-american-society-hematology,1571919.html

 
IMNP
0.3812-0.0598(-13.56%)Jun 24 4:00 PMEDT